Pfizer raises full-year outlook, names Cecile Guegan as CFO
Pfizer lifted full-year revenue guidance to $62 billion–$64 billion, beat third-quarter estimates and named finance veteran Cecile Guegan CFO as newer products offset declining Covid sales.
Topic
Pharmaceuticals
Topic
Pharmaceuticals
Merck Q3 Earnings: Keytruda Qlex Hits $830 Million as Guidance Rises
Merck raised its adjusted profit outlook to $2.77–$2.82 per share after Q3 revenue of $18.09 billion beat estimates, powered by K…
India Caps Cancer Drug Margins After Court Calls Mark-Ups 'Extortion'
India will cut prices on 137 cancer drugs by up to 70% from next month after supreme court judges called hospital mark-ups 'extor…
Acta Pharmaceuticals Lands $24 Million Seed Round
Acta Pharmaceuticals raised $24 million in seed funding, FinSMEs reports. The round size marks an outsized early-stage bet on the…
London Private Equity Firm Buys Danish Pharma Manufacturer
A London private equity firm has bought a Danish pharmaceutical manufacturer in its debut deal, The Wall Street Journal reports —…
El Segundo Startup Aims to Manufacture Medicine in Space
An El Segundo startup wants to manufacture medicine in space, betting orbital production can outperform Earth-bound pharmaceutica…
Astrocyte Pharmaceuticals Banks $9.5M in Series B Round
Astrocyte Pharmaceuticals raised $9.5 million in Series B funding, per FinSMEs, adding capital to advance its astrocyte-targeting…
JW Pharmaceutical Buys Group's VC Arm Solidus for $22 Million
JW Pharmaceutical has agreed to acquire Solidus, the venture capital arm of its own business group, for $22 million, Dealroom.co…
Johnson & Johnson Returns 58% on Slower Growth Than Eli Lilly
JNJ returned 58% in twelve months, beating Eli Lilly's 54% despite growing revenue at 8.1% versus Lilly's 49.6%. The rally is a b…